Clinical Outcomes of Adjunctive Sustained-Release Intravitreal Dexamethasone Implants in Tuberculosis-Associated Multifocal Serpigenoid Choroiditis

References

• Dogra M, Singh R, Agarwal A, et al. Epidemiology of uveitis in a tertiary-care referral institute in north India. Ocul Immunol Inflamm. 2016 Dec;12:1–8.
   Google Scholar
• Agrawal R, Gupta B, González-López JJ, et al. Spectrum of choroidal involvement in presumed ocular tuberculosis: report from a population with low endemic setting for tuberculosis. Ocul Immunol Inflamm. 2017;25(1):97–104. doi:10.3109/09273948.2015.1087577.
   PubMed Web of Science ®Google Scholar
• Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2014;23(1):7–13. doi:10.3109/09273948.2014.967358.
   PubMed Web of Science ®Google Scholar
• Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118(4):772–777. doi:10.1016/j.ophtha.2010.08.011.
   PubMed Web of Science ®Google Scholar
• Balne P, Modi R, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthal Inflamm Infec. 2014;4(1):10. doi:10.1186/1869-5760-4-10.
   PubMedGoogle Scholar
• Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146(5):772–779. doi:10.1016/j.ajo.2008.06.011.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gupta B, Gonzalez-Lopez JJ, et al. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):40–46. doi:10.3109/09273948.2014.986584.
   PubMed Web of Science ®Google Scholar
• Gupta V, Bansal R. Gupta A. Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol. 2011;152(5):857–63.e2. doi:10.1016/j.ajo.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Basu S, Nayak S, Padhi TR, Das T. Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting. Eye. 2013;27(5):657–662. doi:10.1038/eye.2013.5.
   PubMed Web of Science ®Google Scholar
• Weijtens O, Schoemaker RC, Lentjes EG, Romijn FP, Cohen AF, Van Meurs JC. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology. 2000;107:1932–1938.
   PubMed Web of Science ®Google Scholar
• Uchiyama E, Papaliodis GN, Lobo AM, Sobrin L. Side-effects of anti-inflammatory therapy in uveitis. Semin Ophthalmol. 2014;29:456–467. doi:10.3109/08820538.2014.959203.
   PubMed Web of Science ®Google Scholar
• Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129(5):545. doi:10.1001/archophthalmol.2010.339.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Berchicci L, Luliano L, Modorati G, Bandello F. Dexamethasone intravitreal implant in serpiginous choroiditis. Br J Ophthalmol. 2016:bjophthalmol-2015-307820. doi:10.1136/bjophthalmol-2015-307820.
   Web of Science ®Google Scholar
• Tan HY, Agarwal A, Lee CS, et al. Management of noninfectious posterior uveitis with intravitreal drug therapy. Clin Ophthalmol. 2016;10:1983–2020. doi:10.2147/opth.s89341.
   PubMed Web of Science ®Google Scholar
• Chang-Lin J-E, Attar M, Acheampong AA, et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;52(1):80–86. doi:10.1167/iovs.10-5285.
   PubMed Web of Science ®Google Scholar
• Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol. 1999;83(9):1050–1055.
   PubMed Web of Science ®Google Scholar
• Ho DCW, Agarwal A, Lee CS, et al. A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis. Ocul Immunol Inflamm. 2016:1–8. doi:10.1080/09273948.2016.1245758.
   Web of Science ®Google Scholar
• Soheilian M, Ramezani A, Azimzadeh A, et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118(1):134–141. doi:10.1016/j.ophtha.2010.04.020.
   PubMed Web of Science ®Google Scholar
• Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013 May-Jun;58(3):203–232. doi:10.1016/j.survophthal.2012.08.008.
   PubMed Web of Science ®Google Scholar
• Indian Council of Medical Research. INDEX-TB guidelines. http://www.icmr.nic.in/guidelines/TB/Index-TB%20Guidelines%20-%20green%20colour%202594164.pdf. Accessed July 14, 2017.
   Google Scholar
• Fonollosa A, Valsero S, Artaraz J, Ruiz-Arruza I. Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis. J Ophthalmic Inflamm Infect. 2016;6(1):31. doi:10.1186/s12348-016-0101-4.
   PubMed Web of Science ®Google Scholar
• Pathengay A. Intravitreal triamcinolone acetonide in serpiginous choroidopathy. Ind J Ophthalmol. 2005;53(1):77–79.
   PubMedGoogle Scholar
• Pelegrín L, De La Maza MS, Molins B, Ríos J, Adán A. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Eye. 2015;29(7):943–950.
   PubMed Web of Science ®Google Scholar
• Pathengay A, Shah GY, Das T, Sharma S. Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis. Am J Ophthalmol. 2006;141(5):938–940.
   PubMed Web of Science ®Google Scholar
• Nazari H, Karakousis PC, Rao NA. Replication of Mycobacterium tuberculosis in retinal pigment epithelium. JAMA Ophthalmol. 2014 Jun;132(6):724–729. doi:10.1001/jamaophthalmol.2014.270.
   PubMed Web of Science ®Google Scholar
• Llorenç V, Mesquida M, Molins B, Gonzalez-Martín J, Sainz De La Maza M, Adán A. Bacillus Calmette–Guérin infection and cytotoxicity in the retinal pigment epithelium. Ocul Immunol Inflamm. 2016;25:1–7.
   Google Scholar